Tag: AUROBINDO PHARMA
Aurobindo Pharma Develops 14 Biosimilar Products
Aurobindo Pharma, a prominent player in the generic pharmaceutical industry, is significantly broadening its specialty
Read MoreAurobindo Pharma China Facility Set to Begin Production in Q3 FY25
Aurobindo Pharma anticipates initiating production at its new facility in China during the upcoming quarter,
Read MoreUSFDA Warns Aurobindo’s Eugia Pharma with a Warning Letter
Eugia Pharma Specialities, a fully owned subsidiary of Aurobindo Pharma, has recently received a warning
Read MoreAurobindo Pharma obtains marketing authorization for Trastuzumab Biosimilar in India
Aurobindo Pharma has achieved a significant milestone in its efforts to combat breast cancer with
Read MoreAurobindo’s TheraNym Biologics Signs Pact with MSD for Biologics Manufacturing
Aurobindo Pharma Limited has announced that its wholly-owned subsidiary, TheraNym Biologics Private Limited, has entered
Read MoreAurobindo Pharma reports increase in Q4 PAT
Aurobindo Pharma has announced a robust financial performance for the fourth quarter ending March 31,
Read MoreAurobindo Pharma’s Rajasthan Facility Wraps Up US FDA Audit with 9 Observations
Aurobindo Pharma, a leading pharmaceutical company, has announced the conclusion of a United States Food
Read More